TruGraf blood test for liver transplant patients
Part of Digestive system, Immune system & allergy clinical trials.
This trial studies a new blood test called TruGraf for people who are waiting for or have recently received a liver transplant due to certain autoimmune liver diseases. The test may help doctors monitor your transplant health without needing a needle biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- Be on the waiting list for a liver transplant or have received one within the last 30 days
- Have a diagnosis of autoimmune hepatitis, primary biliary cirrhosis, or primary sclerosing cholangitis as the main reason for transplant
- Be receiving a liver transplant for the first time and only a liver (not other organs)
- Be willing to have extra blood draws for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This study uses a blood test called TruGraf to check for liver transplant problems. It may help diagnose issues without a biopsy.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This trial is testing a new blood test called T-ID that monitors your immune system after a kidney transplant. It may help doctors detect early signs of rejection so they can adjust your treatment before problems start.
Hear when a new Autoimmune Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.